Press release
Investigation announced for Investors in shares of AVROBIO, Inc. (NASDAQ: AVRO)
An investigation for investors in AVROBIO, Inc. (NASDAQ: AVRO) shares over potential securities laws violations by AVROBIO, Inc.
Investors who purchased shares of AVROBIO, Inc. (NASDAQ: AVRO), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by AVROBIO, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Cambridge, MA based AVROBIO, Inc., a clinical-stage gene therapy company, focuses on developing ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose in the United States. On March 16, 2020, AVROBIO, Inc. released its financial and operating results for the fourth quarter and fiscal year 2019. The Company reported a net loss of $22.7 million for the quarter and a loss of $73 million for the year. These results are especially negative when compared to the Company's loss of $16 million for the fourth quarter of 2018 and $46.4 million for the fiscal year of 2018. AVROBIO, Inc. commented on its increasing losses, staying: "These increases were due to increased research and development expenses, as well as increased general and administrative expenses." Shares of AVROBIO, Inc. (NASDAQ: AVRO) declined from $29.32 per share on February 12, 2020, to as low as $9.76 per share on March 17, 2020.
Those who purchased shares of AVROBIO, Inc. (NASDAQ: AVRO) have certain options and should contact the Shareholders Foundation.
About:
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in shares of AVROBIO, Inc. (NASDAQ: AVRO) here
News-ID: 1986840 • Views: …
More Releases from Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders…
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced.
Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:…
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc.
Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
More Releases for AVRO
Gaucher Disease Market on Track for Major Expansion by 2032, According to DelveI …
DelveInsight's "Gaucher Disease Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Gaucher Disease, historical and forecasted epidemiology as well as the Gaucher Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Gaucher Disease market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Gaucher Disease Market Forecast
https://www.delveinsight.com/sample-request/gauchers-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Gaucher's Disease Treatment Market Size 2032 | Sanofi, Genzyme, Orphazyme, Avro …
As per DelveInsight's assessment, the Gaucher Disease market size in the 7MM is anticipated to increase in the coming years owing to the rising prevalent population of Gaucher Disease patients in the 7MM countries. The launch of the upcoming therapies will also fuel market growth. DelveInsight's "Gaucher's Disease Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as…
Children Dining Chairs Market is Set To Fly High in Years to Come | Kartell, Gra …
Advance Market Analytics published a new research publication on "Children Dining Chairs Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Children Dining Chairs market was mainly driven by the increasing R&D spending across the world.
Get Free Exclusive PDF Sample…
Global Runway Luggage Cart Market Size,Share & Forecast 2022-2028|ACCESSAIR Syst …
Global Market For Runway Luggage Cart Estimated At US$ Million In The Year 2022, Is Projected To Reach A Revised Size Of US$ Million By 2028, Growing At A CAGR Of % During The Forecast Period 2022-2028.
Los Angeles, United States October 2022,- The research study presented here is a brilliant compilation of different types of analysis of critical aspects of the global Runway Luggage Cart market. It sheds light on…
Airport High Loader Market qualitative and quantitative analysis To 2028| Avioge …
The Airport High Loader Market Research study 2021-2028 enhances the decision making capabilities and helps to create potent counter strategies to obtain competitive advantage says a latest research report at The Insight Partners. The Airport High Loader Market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.
Airport High Loader also known as cargo loader is an airport equipment specially designed for…
AVROBIO, Inc. (NASDAQ: AVRO) Investor Investigation over potential Wrongdoing
Certain directors of AVROBIO, Inc are under investigation over potential breaches of fiduciary duties.
Investors who purchased shares of AVROBIO, Inc. (NASDAQ: AVRO) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain AVROBIO directors breached their fiduciary duties and caused damage to the company and its shareholders.
Cambridge, MA based AVROBIO, Inc., a clinical-stage gene therapy…
